QUANTITATIVE MEMBRANE PROTEOMICS APPLYING NARROW RANGE PEPTIDE ISOELECTRIC FOCUSING FOR STUDIES OF SMALL CELL LUNG CANCER RESISTANCE MECHANISMS

被引：0
|
作者：
Eriksson, Hanna [1 ,2 ]
Lengqvist, Johan [1 ,3 ]
Hedlund, Joel [4 ]
Uhlen, Kristina [5 ]
Orre, Lukas M. [1 ,3 ]
Bjellqvist, Bengt [5 ]
Persson, Bengt [6 ]
Lehtio, Janne [1 ,3 ]
Jakobsson, Per-Johan [1 ,2 ]
机构：
[1] Karolinska Univ Hosp, Karolinska Biom Ctr, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Rheumatol Unit, Dept Med, S-17176 Stockholm, Sweden
[3] Karolinska Inst, Dept Pathol & Oncol, S-17176 Stockholm, Sweden
[4] Linkoping Univ, IFM Bioinformat, S-58183 Linkoping, Sweden
[5] GE Healthcare Biosci AB, S-75184 Uppsala, Sweden
[6] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 5C期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
190
引用
收藏
页码：3275 / 3276
页数：2
相关论文
共 50 条
  • [1] Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms
    Eriksson, Hanna
    Lengqvist, Johan
    Hedlund, Joel
    Uhlen, Kristina
    Orre, Lukas M.
    Bjellqvist, Bengt
    Persson, Bengt
    Lehtio, Janne
    Jakobsson, Per-Johan
    PROTEOMICS, 2008, 8 (15) : 3008 - 3018
  • [2] Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics
    Pedersen, Shona
    Jensen, Katrine Papendick
    Honore, Bent
    Kristensen, Soren Risom
    Pedersen, Camilla Holm
    Szejniuk, Weronika Maria
    Maltesen, Raluca Georgiana
    Falkmer, Ursula
    CLINICAL PROTEOMICS, 2022, 19 (01)
  • [3] Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics
    Shona Pedersen
    Katrine Papendick Jensen
    Bent Honoré
    Søren Risom Kristensen
    Camilla Holm Pedersen
    Weronika Maria Szejniuk
    Raluca Georgiana Maltesen
    Ursula Falkmer
    Clinical Proteomics, 2022, 19
  • [4] Mechanisms of immunotherapy resistance in small cell lung cancer
    Nie, Yunan
    Schalper, Kurt A.
    Chiang, Anne
    CANCER DRUG RESISTANCE, 2024, 7
  • [5] Immunotherapy for small cell lung cancer: mechanisms of resistance
    Hamilton, Gerhard
    Rath, Barbara
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (05) : 423 - 432
  • [6] Quantitative proteomics as a tool to identify resistance mechanisms in erlotinib-resistant subclones of the non-small cell lung cancer cell line HCC827
    Jacobsen, K.
    Lund, R. R.
    Beck, H. C.
    Ditzel, H. J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 30 - 30
  • [7] Chemotherapy Immunophenoprofiles in Non-Small-Cell Lung Cancer by Personalized Membrane Proteomics
    Putri, Denise Utami
    Feng, Po-Hao
    Hsu, Yuu-Hueih
    Lee, Kang-Yun
    Jiang, Feng-Wen
    Kuo, Lu-Wei
    Chen, Yu-Ju
    Han, Chia-Li
    PROTEOMICS CLINICAL APPLICATIONS, 2018, 12 (02)
  • [8] Mechanisms of resistance to pemetrexed in non-small cell lung cancer
    Liang, Jiaqi
    Lu, Tao
    Chen, Zhencong
    Zhan, Cheng
    Wang, Qun
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1107 - 1118
  • [9] Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Hye-Young Min
    Ho-Young Lee
    Archives of Pharmacal Research, 2021, 44 : 146 - 164
  • [10] MECHANISMS OF ACQUIRED RESISTANCE TO MTOR INHIBITOR IN SMALL CELL LUNG CANCER
    Toyokawa, Masaru
    Noro, Rintaro
    Seike, Masahiro
    Nishijima, Nobuhiko
    Kitamura, Kazuhiro
    Minegishi, Yuji
    Soeno, Chie
    Matsuda, Kuniko
    Kubota, Kaoru
    Gemma, Akihiko
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S465 - S465
12345